← Leaderboards
Ana Fernandez-Sesma
Icahn School Of Medicine At Mount Sinai
$24,867,465
Attributed
$25,079,340
Total exposure
16
Grants
16
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $15.5M · FY2008–25$20M$15M$10M$5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$81,513,660 · 18
By mechanism
U19$75,353,524 · 15
R01$3,326,717 · 1
P01$2,372,786 · 1
R21$460,633 · 1
Top collaborators
- Eva Harris12 shared
- Viviana A Simon6 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Florian Krammer$130,401,178
- Viviana A Simon$21,556,427
- Allen Zheng$179,804
- Goran Bajic$3,116,277
- Robert Sebra$1,367,209
Others in their field
Top investigators on “Immune”
- Lawrence Corey · Fred Hutchinson Cancer Center$680,290,567
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$541,067,641
- Bambra Strokes · Ppd Development Lp$526,656,217
- Barton F Haynes · Duke University$470,748,611
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
- Judith S. Currier · University Of California Los Angeles$334,425,492
Research focus
ImmuneInfectionImmune ResponseCellsVaccinesViralDengue VirusResponseDengueImmunologyVirusSamplingVirus DiseasesImmunityVaccinationDesignCollaborationsSerotypingPeripheral Blood Mononuclear CellLaboratoriesGenerationsProgramsIn VivoBase
Grant awards (65)
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)$2,265,730
U19 · FY2025 · AI · contact PI
Immune Phenotyping Core$520,005
U19 · FY2025 · AI · contact PI
Administrative Core$406,803
U19 · FY2025 · AI · contact PI
Immune phenotyping of human immune responses to dengue vaccination and challenge$176,891
U19 · FY2025 · AI · contact PI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)$2,265,730
U19 · FY2024 · AI · contact PI
Immune Phenotyping Core$548,082
U19 · FY2024 · AI · contact PI
Administrative Core$400,000
U19 · FY2024 · AI · contact PI
Phenotyping of human immune responses to dengue vaccination and infection in Argentina$400,000
U19 · FY2024 · AI · contact PI
US-Cuba Administrative Supplement to the Viral Immunity and Vaccination (VIVA) Human Immunology Project Consortium$399,999
U19 · FY2024 · AI · contact PI
Administrative Core$315,121
U19 · FY2024 · AI · contact PI
Immune phenotyping of human immune responses to dengue vaccination and challenge$135,718
U19 · FY2024 · AI · contact PI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)$2,265,730
U19 · FY2023 · AI · contact PI
Immune Phenotyping Core$522,189
U19 · FY2023 · AI · contact PI
Administrative Core$300,637
U19 · FY2023 · AI · contact PI
Immune phenotyping of human immune responses to dengue vaccination and challenge$140,986
U19 · FY2023 · AI · contact PI
Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)$2,265,730
U19 · FY2022 · AI · contact PI
Immune Phenotyping Core$283,217
U19 · FY2022 · AI · contact PI
Administrative Core$283,217
U19 · FY2022 · AI · contact PI
Immune phenotyping of human immune responses to dengue vaccination and challenge$283,216
U19 · FY2022 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$3,000,000
U19 · FY2021 · AI · contact PI
Core A - Administrative Core$300,000
U19 · FY2021 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$299,999
U19 · FY2021 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$152,665
U19 · FY2021 · AI · contact PI
Administrative Supplement for the HEROS Study Serology$152,665
U19 · FY2021 · AI · contact PI
Mount Sinai IMPACC COVID-19 Cores$5,198,360
U19 · FY2020 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$5,198,360
U19 · FY2020 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$3,000,000
U19 · FY2020 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$959,574
U19 · FY2020 · AI · contact PI
Project-003$423,750
U19 · FY2020 · AI · contact PI
CHARACTERIZATION OF INNATE AND ADAPTIVE IMMUNE RESPONSES INDUCED BY DIFFERENT HUMAN CORONAVIRUSES IN HUMAN PRIMARY SYSTEMS$423,750
U19 · FY2020 · AI · contact PI
Core A - Administrative Core$298,233
U19 · FY2020 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$5,858,923
U19 · FY2019 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$1,182,798
U19 · FY2019 · AI · contact PI
Core A - Administrative Core$247,154
U19 · FY2019 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$7,340,996
U19 · FY2018 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$1,632,007
U19 · FY2018 · AI · contact PI
Core A - Administrative Core$320,563
U19 · FY2018 · AI · contact PI
Core A - Administrative Core$75,220
U19 · FY2018 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$75,220
U19 · FY2018 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$6,860,460
U19 · FY2017 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$1,284,791
U19 · FY2017 · AI · contact PI
Core A - Administrative Core$560,419
U19 · FY2017 · AI · contact PI
Modulation of Innate and Adaptive Immunity by Dengue Virus$380,183
R01 · FY2017 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$7,165,769
U19 · FY2016 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$517,623
U19 · FY2016 · AI · contact PI
Core A - Administrative Core$451,949
U19 · FY2016 · AI · contact PI
Modulation of Innate and Adaptive Immunity by Dengue Virus$380,183
R01 · FY2016 · AI · contact PI
HUMAN TONSIL EXPLANTS AS A NOVEL MODEL FOR STUDYING DENGUE VIRUS INFECTION$209,129
R21 · FY2016 · AI · contact PI
Dengue Human Immunology Project Consortium (DHIPC)$7,495,258
U19 · FY2015 · AI · contact PI
Project 3 - Ex vivo immune profiling of dengue viruses and vaccines$530,744
U19 · FY2015 · AI · contact PI
Modulation of Innate and Adaptive Immunity by Dengue Virus$380,183
R01 · FY2015 · AI · contact PI
HUMAN TONSIL EXPLANTS AS A NOVEL MODEL FOR STUDYING DENGUE VIRUS INFECTION$251,504
R21 · FY2015 · AI · contact PI
Core A - Administrative Core$167,273
U19 · FY2015 · AI · contact PI
HIV infection and innate defense mechanisms in dendritic cells$553,417
P01 · FY2014 · AI · contact PI
Modulation of Innate and Adaptive Immunity by Dengue Virus$380,183
R01 · FY2014 · AI · contact PI
HIV infection and innate defense mechanisms in dendritic cells$430,023
P01 · FY2013 · AI · contact PI
HIV infection and innate defense mechanisms in dendritic cells$451,939
P01 · FY2012 · AI · contact PI
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUS$332,254
R01 · FY2012 · AI · contact PI
HIV infection and innate defense mechanisms in dendritic cells$460,524
P01 · FY2011 · AI · contact PI
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUS$332,254
R01 · FY2011 · AI · contact PI
HIV infection and innate defense mechanisms in dendritic cells$476,883
P01 · FY2010 · AI · contact PI
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUS$335,610
R01 · FY2010 · AI · contact PI
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUS$127,867
R01 · FY2010 · AI · contact PI
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUS$339,000
R01 · FY2009 · AI · contact PI
MODULATION OF INNATE AND ADAPTIVE IMMUNITY BY DENGUE VIRUS$339,000
R01 · FY2008 · AI · contact PI